Concepedia

Phase I study pilot arms of radiotherapy and carmustine with temozolomide for anaplastic astrocytoma (Radiation Therapy Oncology Group 9813): implications for studies testing initial treatment of brain tumors

Susan M. Chang, Wendy Seiferheld, Walter J. Curran, R. Share, J. Atkins, Ali Choucair, John J. Kresl, Louisa Thoron, Gregory Cairncross, Mark R. Gilbert,

International Journal of Radiation Oncology*Biology*Physics · 2004 · 26 citations · 15 references

DOI

Concepts

References

15

Multicenter Phase II Trial of Temozolomide in Patients With Anaplastic Astrocytoma or Anaplastic Oligoastrocytoma at First Relapse

W.K. Alfred Yung, Michael D. Prados, Ricardo Yayá et al. · Journal of Clinical Oncology · 1999 · 763 citations

, , +17

Phase I Trial of Temozolomide Plus <i>O</i><sup>6</sup>-Benzylguanine for Patients With Recurrent or Progressive Malignant Glioma

Jennifer A. Quinn, Annick Desjardins, Jon Weingart et al. · Journal of Clinical Oncology · 2005 · 292 citations · Full text

, , +16

Temozolomide: A new oral cytotoxic chemotherapeutic agent with promising activity against primary brain tumours

S.M. O'Reilly, E.S. Newlands, M Brampton et al. · European Journal of Cancer · 1993 · 280 citations

, , +9

Incorporating Toxicity Considerations Into the Design of Two-Stage Phase II Clinical Trials

John Bryant, Roger Day · Biometrics · 1995 · 261 citations

, , +14

Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma

Mark Bower, E.S. Newlands, N M Bleehen et al. · Cancer Chemotherapy and Pharmacology · 1997 · 221 citations

, , +13